Table 1

Ascertainment of pregnant women with depression from dispensing data, 2002-2005
Pregnancy Risk Code Dispenses PBS cases PBS, no HMDS PBS and HMDS
N % N % N % N %
Pharmaceutical Benefits Scheme 20879 100.0% 4485 100.0% 3586 80.0% 899 20.0%
Sertraline hydrochloride C 5536 26.5% 1340 29.9% 1082 30.2% 258 28.7%
Citalopram hydrobromide C 4784 22.9% 1136 25.3% 897 25.0% 239 26.6%
Paroxetine hydrochloride* C/D 3180 15.2% 676 15.1% 565 15.8% 111 12.3%
Venlafaxine hydrochloride B2 3146 15.1% 581 13.0% 430 12.0% 142 15.8%
Fluoxetine hydrochloride C 1509 7.2% 364 8.1% 280 7.8% 84 9.3%
Escitalopram oxalate C 775 3.7% 241 5.4% 189 5.3% 52 5.8%
Mirtazapine B3 510 2.4% 140 3.1% 85 2.4% 55 6.1%
Fluvoxamine maleate C 412 2.0% 140 3.1% 115 3.2% 25 2.8%
Amitriptyline hydrochlorine C 273 1.3% 105 2.3% 79 2.2% 26 2.9%
Dothiepin hydrochloride C 376 1.8% 78 1.7% 62 1.7% 16 1.8%
Moclobemide B3 92 0.4% 40 0.9% 34 0.9% 6 0.7%
Doxepine hydrochloride C 137 0.7% 32 0.7% 20 0.6% 12 1.3%
Reboxetine mesilate B1 89 0.4% 24 0.5% 16 0.4% 8 0.9%
Imipramine hydrochloride C 31 0.1% 8 0.2% 6 0.2% <5 0.2%
Mianserin hydrochloride B2 9 0.0% 6 0.1% <5 0.1% <5 0.2%
Nefazodone hydrochloride B3 14 0.1% 5 0.1% <5 0.1% <5 0.1%
Nortriptyline hydrochloride C 6 0.0% <5 0.1% <5 0.1% 0 0.0%

Pregnancy Risk Code: Australian category of risk for the medicine’s use in pregnancy.

* changed from category C to D, September 2005.

Colvin et al.

Colvin et al. BMC Pregnancy and Childbirth 2013 13:63   doi:10.1186/1471-2393-13-63

Open Data